Clinical Trial of Essential Fatty Acids for Dry Eye Disease: Planning Grant
Clinical Trial of Essential Fatty Acids for Dry Eye Disease: Planning Grant
批准号:
7585217
负责人:
PENNY ASBELL
金额:
$22.33万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2011-03-31
关键词:
AddressAdrenal Cortex HormonesAdultAdverse effectsAnimal ModelAnti-Inflammatory AgentsArtificial TearsBenefits and RisksBiological MarkersBlindnessChronicChronic DiseaseClinicalClinical ResearchClinical TrialsCyclosporineCyclosporinsDataDevelopmentDietDiseaseDisease OutcomeDoseDouble-Blind MethodDrug IndustryElderlyEnsureEssential Fatty AcidsEsthesiaEthicsEyeEye diseasesFeasibility StudiesForeign BodiesGoalsGrantHealth ProfessionalHumanImmuneImmune responseImpairmentInflammationInflammatoryIntakeKnowledgeLaboratory StudyLeadManualsManufacturer NameMediatingMethodsMulti-Institutional Clinical TrialOperative Surgical ProceduresOphthalmologistOralOutcomeOutcome MeasurePainPathogenesisPathologyPatient SelectionPatientsPhotophobiaPlacebo ControlPolyunsaturated Fatty AcidsPostmenopauseProceduresQuality ControlRandomizedRandomized Controlled TrialsReactionRecruitment ActivityResearch DesignRoleSafetySample SizeSeveritiesSigns and SymptomsSiteSymptomsTestingTissuesUnited StatesUnited States National Institutes of HealthVisionWomanbasechronic paincombatdietary supplementseffective therapyefficacy testingeye drynessfinancial incentivehuman diseaseimprovedirritationmenocular surfaceplacebo controlled studypreventrandomized placebo controlled trialresearch clinical testingstandard measuretreatment duration
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The proposed study will examine in a scientific, controlled way the role of essential fatty acids (EFA) in the treatment of dry-eye disease (DED). Moderate to severe DED is an inflammatory disease, characterized by complaints of eye irritation, eye pain, foreign-body sensation, chronic red eyes, photophobia, fluctuation in vision, and/or loss of vision. DED is a widespread, growing problem with serious consequences. DED is the most common complaint to present in the ophthalmologist's office, with 10-20% of adults in the United States suffering from it. It appears to be more common in women than in men, particularly postmenopausal women. At present, moderate to severe DED is inadequately treated. EFA are polyunsaturated fatty acids which are essential in the human diet since they cannot be synthesized by the body. EFA have been shown in laboratory studies, animal models and some human clinical trials to ameliorate inflammatory reactions and they are widely available over the counter (OTC), purporting to combat or prevent diseases associated with inflammation, including DED, despite the fact that there have been no large, well-controlled and planned, randomized double-blind clinical trials to test the efficacy and safety of EFA for treatment of DED. The proposed study will address this gap in information. The specific aims of this Planning Grant are to resolve key issues in order to develop a detailed Manual of Operations, to document the ability to recruit suitable subjects, and to perform a small feasibility study to refine procedures and finalize the Manual of Operations for a multi-centered, randomized, placebo-controlled study of EFAs in moderate to severe DED. This is in line with NIH goals of increasing knowledge of ocular surface disease and inflammation, and of addressing human diseases more common in women, and will expand the evidence available on supplement-use to prevent and treat chronic disease.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.exer.2013.03.018
发表时间:
2013-06
期刊:
EXPERIMENTAL EYE RESEARCH
影响因子:
3.4
作者:
[Epstein, Seth P., Gadaria-Rathod, Neha, Wei, Yi, Maguire, Maureen G., Asbell, Penny A.]
通讯作者:
Asbell, Penny A.
sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.
DOI:
10.1167/iovs.10-6350
发表时间:
2011-07
期刊:
Investigative ophthalmology & visual science
影响因子:
4.4
作者:
[Yi Wei;S. Epstein;S. Fukuoka;N. Birmingham;Xiu-Min Li;P. Asbell]
通讯作者:
Yi Wei;S. Epstein;S. Fukuoka;N. Birmingham;Xiu-Min Li;P. Asbell
Dry Eye Evaluation and Management (DREAM) Study
-
批准号:8415133
-
项目类别:
-
资助金额:$44.32万
-
财政年份:2013
-
负责人:PENNY ASBELL
-
依托单位:
Dry Eye Evaluation and Management (DREAM) Study
-
批准号:9265186
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2013
-
负责人:PENNY ASBELL
-
依托单位:
Dry Eye Evaluation and Management (DREAM) Study
-
批准号:8737264
-
项目类别:
-
资助金额:$49.94万
-
财政年份:2013
-
负责人:PENNY ASBELL
-
依托单位:
Dry Eye Evaluation and Management (DREAM) Study
-
批准号:8918822
-
项目类别:
-
资助金额:$15.95万
-
财政年份:2013
-
负责人:PENNY ASBELL
-
依托单位:
Clinical Trial of Essential Fatty Acids for Dry Eye Disease: Planning Grant
-
批准号:7386987
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2008
-
负责人:PENNY ASBELL
-
依托单位:
HERPES EYE DISEASE
-
批准号:2163393
-
项目类别:
-
资助金额:$15.46万
-
财政年份:1992
-
负责人:PENNY ASBELL
-
依托单位:
HERPES EYE DISEASE
-
批准号:2163395
-
项目类别:
-
资助金额:$15.03万
-
财政年份:1992
-
负责人:PENNY ASBELL
-
依托单位:
REGIONAL CENTER, HERPETIC EYE DISEASE STUDY, PHASE II
-
批准号:3559976
-
项目类别:
-
资助金额:$12.03万
-
财政年份:1992
-
负责人:PENNY ASBELL
-
依托单位:
REGIONAL CENTER, HERPETIC EYE DISEASE STUDY, PHASE II
-
批准号:3559977
-
项目类别:
-
资助金额:$13.47万
-
财政年份:1992
-
负责人:PENNY ASBELL
-
依托单位:
HERPES EYE DISEASE
-
批准号:2605201
-
项目类别:
-
资助金额:$10.95万
-
财政年份:1992
-
负责人:PENNY ASBELL
-
依托单位:
HERPES EYE DISEASE
-
批准号:2163394
-
项目类别:
-
资助金额:$16.03万
-
财政年份:1992
-
负责人:PENNY ASBELL
-
依托单位: